Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7825)
All Articles published online
|
Publishing Process of This Article
|
Aug 15, 2015 (publication date) through Dec 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Quéro L, Guillerm S, Hennequin C. Neoadjuvant or adjuvant therapy for gastric cancer. World J Gastrointest Oncol 2015; 7(8): 102-110 [PMID: 26306142 DOI: 10.4251/wjgo.v7.i8.102] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v7/i8/102.htm |
| Number | Citing Articles |
| 1 |
Yoshinaga Okugawa, Yuji Toiyama, Akira Yamamoto, Tsunehiko Shigemori, Takashi Ichikawa, Chengzeng Yin, Akihiro Suzuki, Hiroyuki Fujikawa, Hiromi Yasuda, Junichiro Hiro, Shigeyuki Yoshiyama, Masaki Ohi, Toshimitsu Araki, Donald C. McMillan, Masato Kusunoki. Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition-inflammation markers of outcome in patients with gastric cancer. Clinical Nutrition 2020; 39(4): 1209 doi: 10.1016/j.clnu.2019.05.009
|
| 2 |
Rui Xie, Haibo Wang, Hai Jin, Guorong Wen, Biguang Tuo, Jingyu Xu. NHE1 is upregulated in gastric cancer and regulates gastric cancer cell proliferation, migration and invasion. Oncology Reports 2017; 37(3): 1451 doi: 10.3892/or.2017.5386
|
| 3 |
Yuji Toiyama, Hiromi Yasuda, Masaki Ohi, Shigeyuki Yoshiyama, Toshimitsu Araki, Koji Tanaka, Yasuhiro Inoue, Yasuhiko Mohri, Masato Kusunoki. Clinical impact of preoperative albumin to globulin ratio in gastric cancer patients with curative intent. The American Journal of Surgery 2017; 213(1): 120 doi: 10.1016/j.amjsurg.2016.05.012
|
| 4 |
H. Ben Salah, M. Bahri, F. Dhouib, J. Daoud. Quelle place pour la chimioradiothérapie postopératoire dans la prise en charge thérapeutique des adénocarcinomes de l’estomac et de la jonction œsogastrique ?. Cancer/Radiothérapie 2016; 20(8): 830 doi: 10.1016/j.canrad.2016.07.100
|
| 5 |
Hanqing Qian, Baorui Liu. Personalized Management of Gastric Cancer. 2017; : 215 doi: 10.1007/978-981-10-3978-2_16
|
| 6 |
Wei Xu, Maneesh K. Beeharry, Wentao Liu, Min Yan, Zhenggang Zhu. Preoperative Chemotherapy for Gastric Cancer: Personal Interventions and Precision Medicine. BioMed Research International 2016; 2016: 1 doi: 10.1155/2016/3923585
|
| 7 |
Xingliang Fang, Jinfang Xu, Ketao Jin, Jun Qian. Combining of immunotherapeutic approaches with chemotherapy for treatment of gastric cancer: Achievements and limitations. International Immunopharmacology 2023; 118: 110062 doi: 10.1016/j.intimp.2023.110062
|
| 8 |
Kanta Ka, Doudou Diouf, Sidy Ka, El Hadj Amadou Sall, Daniele Presti, Mamadou Moustapha Dieng, Papa Macoumba Gaye, Ahmadou Dem. Gastric Adenocarcinoma at the Joliot Curie Institute in Dakar: Epidemiological, Diagnostic and Therapeutic Aspects about 54 Cases. Journal of Cancer Therapy 2021; 12(03): 136 doi: 10.4236/jct.2021.123015
|
| 9 |
Chun-Feng Li, Da-Peng Wang, Ying-Wei Xue. Evaluation of a Multi-Slice Spiral Computed Tomography Perfusion for the Prediction of the Recurrence of Gastric Cancer. Future Oncology 2018; 14(19): 1953 doi: 10.2217/fon-2016-0541
|
| 10 |
Chai Hong Rim, In-Soo Shin, Hye Yoon Lee, Won Sup Yoon, Sunmin Park. Oncologic Benefit of Adjuvant Chemoradiation after D2 Gastrectomy: A Stepwise Hierarchical Pooled Analysis and Systematic Review. Cancers 2020; 12(8): 2125 doi: 10.3390/cancers12082125
|
| 11 |
Li Chen, Ying Hao, Xiliang Cong, Menghua Zou, Sen Li, Lihua Zhu, Hongjiang Song, Yingwei Xue. Peripheral Venous Blood Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Patients With Gastric Cancer Treated With SOX or XELOX Regimen Neoadjuvant Chemotherapy. Technology in Cancer Research & Treatment 2019; 18 doi: 10.1177/1533033819829485
|
| 12 |
Huashe Wang, Honglei Chen, Zhipeng Jiang, Yijia Lin, Xinyou Wang, Jun Xiang, Junsheng Peng. Integrin subunit alpha V promotes growth, migration, and invasion of gastric cancer cells. Pathology - Research and Practice 2019; 215(9): 152531 doi: 10.1016/j.prp.2019.152531
|
| 13 |
Md. Rezaul Islam, Abdur Rauf, Shopnil Akash, Ajoy Kumer, Md Sadique Hussain, Smrity Akter, Jeetendra Kumar Gupta, L.H. Thameemul Ansari, Mir Md. Mahfoj Islam Raj, Talha Bin Emran, Abdullah S.M. Aljohani, Waleed Al Abdulmonem, Rekha Thiruvengadam, Muthu Thiruvengadam. Recent perspective on the potential role of phytocompounds in the prevention of gastric cancer. Process Biochemistry 2023; 135: 83 doi: 10.1016/j.procbio.2023.11.006
|
| 14 |
Zhihao Zhang, Mengmeng Dou, Xiaofang Yao, Hao Tang, Zhubo Li, Xiaoyan Zhao. Potential Biomarkers in Diagnosis of Human Gastric Cancer. Cancer Investigation 2016; 34(3): 115 doi: 10.3109/07357907.2015.1114122
|
| 15 |
Hong-Tao Fu, Ying-Ying Xu, Jing-Jing Tian, Jia-Xin Fu, Shao-Ling Nie, Yan-Yan Tang, Ping Chen, Liang Zong. Long-term efficacy of capecitabine plus oxaliplatin chemotherapy on stage III colon cancer: A meta-analysis. World Journal of Meta-Analysis 2020; 8(1): 27-40 doi: 10.13105/wjma.v8.i1.27
|
| 16 |
Wenwen Wang, Juan Liu, Jianni Qi, Junyong Zhang, Qiang Zhu, Chengyong Qin. RLIP76 increases apoptosis through Akt/mTOR signaling pathway in gastric cancer. Oncology Reports 2016; 36(4): 2216 doi: 10.3892/or.2016.5043
|
| 17 |
Qi Wang, Qiang Zhang, Jiankang Zhu, Linchuan Li, Runzhi Zeng, Huanxin Ding, Zhenmin Li, Tianyi Feng, Ruiqi Hao, Guangyong Zhang. Nomogram for predicting overall survival after curative gastrectomy using inflammatory, nutritional and pathological factors. Clinical and Translational Oncology 2023; 26(4): 1001 doi: 10.1007/s12094-023-03340-0
|
| 18 |
Tolga Dinç, Hikmet Pehlevan Özel, Özgür Akgül, Erdinç Çetinkaya. Is Fibrinogen an Effective Marker for Predicting Mortality in Patients with Gastric Cancer?. Indian Journal of Surgery 2021; 83(S3): 761 doi: 10.1007/s12262-021-02915-x
|
| 19 |
Christina Hadzitheodorou, Rebecca A. Moss, Timothy J. Kennedy, Salma K. Jabbour. Neoadjuvant Chemotherapy and Adjuvant Chemoradiation Therapy in the Treatment of Resected Gastric Adenocarcinoma: A Case Series. Case Reports in Oncology 2017; 10(1): 308 doi: 10.1159/000464280
|
| 20 |
Cheng-Kun Tsai, Ta-Sen Yeh, Ren-Chin Wu, Ying-Chieh Lai, Meng-Han Chiang, Kuan-Ying Lu, Cheng-Yu Hung, Hung-Yao Ho, Mei-Ling Cheng, Gigin Lin. Metabolomic alterations and chromosomal instability status in gastric cancer. World Journal of Gastroenterology 2018; 24(33): 3760-3769 doi: 10.3748/wjg.v24.i33.3760
|
| 21 |
Guo Tianxing, Pan Xiaojie, Zhu Lihuan, Huang Yangyun. Combination of preoperative fibrinogen and neutrophil to lymphocyte ratio is a predictive prognostic factor in ESCC and AEG systematic review. Bioscience Reports 2019; 39(10) doi: 10.1042/BSR20190480
|
| 22 |
Adem AKÇAKAYA. Surgeon’s Neoadjuvan Therapy Approach in Gastric Cancer. Bezmialem Science 2022; 10(4): 398 doi: 10.14235/bas.galenos.2022.75537
|
| 23 |
Ling Qiu, Hui Yang, Gaochao Lv, Ke Li, Guiqing Liu, Wei Wang, Shanshan Wang, Xueyu Zhao, Minhao Xie, Jianguo Lin. Insights into the mevalonate pathway in the anticancer effect of a platinum complex on human gastric cancer cells. European Journal of Pharmacology 2017; 810: 120 doi: 10.1016/j.ejphar.2017.06.035
|